Percutaneous coronary intervention for calcified and resistant lesions.
Pesarini G, Hellig F, Seth A, Shlofmitz RA, Ribichini FL.
EuroIntervention. 2025 Apr 7;21(7):e339-e355. doi: 10.4244/EIJ-D-24-00195.
Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain.
Shanthanna H, Eldabe S, Provenzano DA, Bouche B, Buchser E, Chadwick R, Doshi TL, Duarte R, Hunt C, Huygen FJPM, Knight J, Kohan L, North R, Rosenow J, Winfree CJ, Narouze S.
Reg Anesth Pain Med. 2023 Jun;48(6):273-287. doi: 10.1136/rapm-2022-104097. Epub 2023 Mar 30.
Technical comparison of Abbott's UroVysion() and Biocare's CytoFISH urine fluorescence in situ hybridization (FISH) assays.
Anderson T, Hartman S, Dunn W, Bellin H, Ehlers TW, Groen S, Ramos JA.
Cancer Cell Int. 2023 Dec 8;23(1):314. doi: 10.1186/s12935-023-03156-6.
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y.
Lancet Diabetes Endocrinol. 2022 Sep;10(9):634-644. doi: 10.1016/S2213-8587(22)00187-5. Epub 2022 Jul 30.
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction.
Berg DD, Jhund PS, Docherty KF, Murphy SA, Verma S, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Bengtsson O, Ponikowski P, Sjöstrand M, Solomon SD, McMurray JJV, Sabatine MS.
JAMA Cardiol. 2021 May 1;6(5):499-507. doi: 10.1001/jamacardio.2020.7585.
Design of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopause.
Pinkerton JV, Simon J, Panay N, Seitz C, Parke S, Caetano C, Mellinger U, Haseli Mashhadi N, Haberland C, Atanackovic G, Holz C, Mao G, Morrison M, Nisius S, Schaefers M, Zuurman L.
Menopause. 2024 Jun 1;31(6):522-529. doi: 10.1097/GME.0000000000002350. Epub 2024 Apr 3.
Using the hemolysis index of Abbott's Alinity c for the measurement of plasma free hemoglobin in ECMO patients.
Bürki C, Volleberg M, Brunner D, Schmugge M, Hersberger M.
Clin Biochem. 2022 Feb;100:67-70. doi: 10.1016/j.clinbiochem.2021.11.010. Epub 2021 Nov 23.
Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial.
Turk AS 3rd, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, Levy EI, Snyder KV, Hanel RA, Aghaebrahim A, Woodward BK, Hixson HR, Chaudry MI, Spiotta AM, Rai AT, Frei D, Almandoz JED, Kelly M, Arthur A, Baxter B, English J, Linfante I, Fargen KM, Mocco J.
Lancet. 2019 Mar 9;393(10175):998-1008. doi: 10.1016/S0140-6736(19)30297-1.
Transcaval Access and Closure Best Practices.
Lederman RJ, Greenbaum AB, Khan JM, Bruce CG, Babaliaros VC, Rogers T.
JACC Cardiovasc Interv. 2023 Feb 27;16(4):371-395. doi: 10.1016/j.jcin.2022.12.005.
Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial.
Deisenhofer I, Albenque JP, Busch S, Gitenay E, Mountantonakis SE, Roux A, Horvilleur J, Bakouboula B, Oza S, Abbey S, Theodore G, Lepillier A, Guyomar Y, Bessiere F, Jan Smit J, Mohr Durdez T, Milpied P, Appetiti A, Guerrero D, De Potter T, De Chillou C, Goldbarg S, Verma A, Hummel JD; TAILORED-AF Investigators.
Nat Med. 2025 Apr;31(4):1286-1293. doi: 10.1038/s41591-025-03517-w. Epub 2025 Feb 14.
